Previous studies have reported aberrantly high expression levels of CDC20 in oral squamous cell carcinoma (Mondal et al., 2007), gastric cancer (Kim et al., 2005), and lung adenocarcinoma (Liu et al., 2018). This evidence concerns the gene CDC20 and lung adenocarcinoma.